Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AB126 in Acute Ischemic Stroke
NCT07813130Phase 1Not yet recruiting
- Sponsor
- Aruna Bio
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of AB126 in ischemic stroke (4 arms), sponsored by Aruna Bio. Primary endpoints: Treatment-emergent adverse events at Day 90, Changes in physical and clinical examination findings at Day 90 and 3 more. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
AB126
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07813130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07813130.